Health tech companies made several major funding announcements in August. Here is a list of some of the biggest funding ...

Takeda Pharmaceutical’s Mimrylo is now approved for treating polycythemia vera, a rare blood cancer with limited therapeutic ...

In this episode, we’re joined by Amanda Shafton, practicing CNM and national director of midwifery at Ob Hospitalist Group.

Six months after withdrawing a drug from the U.S. market for a rare liver disease, Alfasigma is reaffirming its commitment to the disorder by paying $300 million for rights to a GSK drug candidate on ...

If AI is not one of the CEO’s top two or three priorities, the organization will produce pilots and slide decks while ...

A new report found that while more than 90% of health systems have deployed third-party AI tools, less than half have the ...

Roivant Sciences subsidiary Priovant Therapeutics received FDA approval for Lisraya as a treatment for the rare inflammatory ...

Epic faced an FTC antitrust probe this week, but that didn't stop the EHR giant from unveiling a wave of new AI tools at its ...

Employers expect healthcare costs to rise 9.2% in 2027 as they seek ways to curb rising hospital and pharmacy costs.

When the healthcare system defaults to uncertainty, people delay care because it feels safer for their wallets. In some cases ...

Onos Health's Series A funding round was led by Costanoa, with support from Flare Capital Partners and CVS Health Ventures.

AstraZeneca and Amgen drug Tezspire met the goals of a Phase 3 test in eosinophilic esophagitis (EoE), a chronic disorder ...